ArticleThe Journal of infectious diseases2026
Chlamydia trachomatis (CT) antibody-mediated opsonophagocytosis is not associated with reduced endometrial or incident infection.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNaturally acquired antibodies to Chlamydia trachomatis (CT) are associated with reduced cervical bacterial burden but not with protection from endometrial or subsequent CT infection. We investigated whether antibody-mediated opsonophagocytosis, a functional measure of humoral immunity, was associated with protection against these clinical outcomes.
methodsSerum samples from 139 women enrolled in the longitudinal T cell Response Against Chlamydia (TRAC) cohort and 11 healthy seronegative controls were evaluated for Fc receptor-mediated opsonophagocytosis of CellTrace Violet-labeled CT elementary bodies using THP-1 monocytes. Associations with anti-chlamydial antibody titers, cervical bacterial burden, endometrial infection, and incident CT infection during 12 months of follow-up were assessed.
resultsOpsonophagocytic activity correlated strongly with anti-chlamydial antibody titers and was significantly higher in seropositive women than in seronegative controls. Although a weak inverse correlation with cervical bacterial burden was observed, neither the proportion of phagocytic cells nor the extent of bacterial uptake was associated with reduced endometrial infection. Similarly, neither measure differed between women who experienced incident CT infection during follow-up and those who remained infection-free.
conclusionsNaturally acquired anti-chlamydial antibodies promoted Fc receptor-mediated uptake of CT; however, antibody-mediated opsonophagocytic activity was not associated with protection from endometrial or subsequent CT infection. These findings suggest that naturally acquired antibody-mediated opsonophagocytic activity is unlikely to serve as a correlate of protection against CT infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.